These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 35387678)

  • 41. Pharmacist attitudes and provision of harm reduction services in North Carolina: an exploratory study.
    Parry RA; Zule WA; Hurt CB; Evon DM; Rhea SK; Carpenter DM
    Harm Reduct J; 2021 Jul; 18(1):70. PubMed ID: 34238306
    [TBL] [Abstract][Full Text] [Related]  

  • 42. 'South Asian cocktail'--the concurrent use of opioids, benzodiazepines and antihistamines among injecting drug users in Nepal and associations with HIV risk behaviour.
    Ojha SP; Sigdel S; Meyer-Thompson HG; Oechsler H; Verthein U
    Harm Reduct J; 2014 May; 11():17. PubMed ID: 24886095
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Harm minimization strategies: opinions of health professionals in rural and remote Australia.
    Peterson GM; Northeast S; Jackson SL; Fitzmaurice KD
    J Clin Pharm Ther; 2007 Oct; 32(5):497-504. PubMed ID: 17875117
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cross-border injection drug use and HIV and hepatitis C virus seropositivity among people who inject drugs in San Diego, California.
    Horyniak D; Wagner KD; Armenta RF; Cuevas-Mota J; Hendrickson E; Garfein RS
    Int J Drug Policy; 2017 Sep; 47():9-17. PubMed ID: 28683432
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Harm reduction interventions in HIV care: a qualitative exploration of patient and provider perspectives.
    Carlberg-Racich S
    PeerJ; 2016; 4():e1932. PubMed ID: 27114879
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Drug preparation, injection-related infections, and harm reduction practices among a national sample of individuals entering treatment for opioid use disorder.
    Marks LR; Durkin MJ; Ayres K; Ellis M
    Harm Reduct J; 2024 Jan; 21(1):16. PubMed ID: 38243269
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evaluation of harm reduction programs on seroincidence of HIV, hepatitis B and C, and syphilis among intravenous drug users in southwest China.
    Ruan Y; Liang S; Zhu J; Li X; Pan SW; Liu Q; Song B; Wang Q; Xing H; Shao Y
    Sex Transm Dis; 2013 Apr; 40(4):323-8. PubMed ID: 23486498
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Integrating Harm Reduction into Outpatient Opioid Use Disorder Treatment Settings : Harm Reduction in Outpatient Addiction Treatment.
    Taylor JL; Johnson S; Cruz R; Gray JR; Schiff D; Bagley SM
    J Gen Intern Med; 2021 Dec; 36(12):3810-3819. PubMed ID: 34159545
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Municipal police support for harm reduction services in officer-led referrals of people who inject drugs in Tijuana, Mexico.
    Baker P; Arredondo J; Borquez A; Clairgue E; Mittal ML; Morales M; Rocha-Jimenez T; Garfein R; Oren E; Pitpitan E; Strathdee SA; Beletsky L; Cepeda JA
    Harm Reduct J; 2021 Jul; 18(1):76. PubMed ID: 34311765
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Integration of a community-based harm reduction program into a safety net hospital: a qualitative study.
    Khan GK; Harvey L; Johnson S; Long P; Kimmel S; Pierre C; Drainoni ML
    Harm Reduct J; 2022 Apr; 19(1):35. PubMed ID: 35414072
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Involvement of people who inject drugs in injection initiation events: a cross-sectional analysis identifying similarities and differences across three North American settings.
    Marks C; Meyers SA; Jain S; Sun X; Hayashi K; Gonzalez-Zuniga P; Strathdee SA; Garfein RS; Milloy MJ; DeBeck K; Cummins K; Werb D
    BMJ Open; 2021 Aug; 11(8):e046957. PubMed ID: 34385244
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinicians' Beliefs and Practices Regarding Drug Use Care of Their Community Health Center Patients.
    Reddy AT; Andersen RM; Gelberg L
    J Addict Med; 2015; 9(6):447-53. PubMed ID: 26441402
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Impact of harm reduction care in HIV clinical settings on stigma and health outcomes for people with HIV who use drugs: study protocol for a mixed-methods, multisite, observational study.
    Kay ES; Creasy S; Batey DS; Coulter R; Egan JE; Fisk S; Friedman MR; Kinsky S; Krier S; Noble V; Turan B; Turan JM; Yu L; Hawk M
    BMJ Open; 2022 Sep; 12(9):e067219. PubMed ID: 36113946
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Legal space for syringe exchange programs in hot spots of injection drug use-related crime.
    Allen ST; Ruiz MS; Jones J; Turner MM
    Harm Reduct J; 2016 Apr; 13():16. PubMed ID: 27112328
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Between Emergency Department Visits: The Role of Harm Reduction Programs in Mitigating the Harms Associated With Injection Drug Use.
    Macias-Konstantopoulos W; Heins A; Sachs CJ; Whiteman PJ; Wingkun NG; Riviello RJ
    Ann Emerg Med; 2021 May; 77(5):479-492. PubMed ID: 33579588
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Harm reduction product distribution in British Columbia.
    Harvard SS; Hill WD; Buxton JA
    Can J Public Health; 2008; 99(6):446-50. PubMed ID: 19149383
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The evolution of addiction treatment and harm reduction programs in Iran: a chaotic response or a synergistic diversity?
    Ekhtiari H; Noroozi A; Farhoudian A; Radfar SR; Hajebi A; Sefatian S; Zare-Bidoky M; Razaghi EM; Mokri A; Rahimi-Movaghar A; Rawson R
    Addiction; 2020 Jul; 115(7):1395-1403. PubMed ID: 31737965
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Intersecting substance use treatment and harm reduction services: exploring the characteristics and service needs of a community-based sample of people who use drugs.
    Krawczyk N; Allen ST; Schneider KE; Solomon K; Shah H; Morris M; Harris SJ; Sherman SG; Saloner B
    Harm Reduct J; 2022 Aug; 19(1):95. PubMed ID: 36002850
    [TBL] [Abstract][Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.